SCHEMBL2372402

SCHEMBL2372402

NC(=O)c1cc(-c2cccc(C(F)(F)F)c2)nc2ccccc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.63
CA1 P00915 3/20 0.63
CA2 P00918 3/20 0.63
CA9 Q16790 3/20 0.63
KDM4E B2RXH2 1/20 0.55
LMNA P02545 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
PDE10A Q9Y233 1/20 0.55
AKR1C3 P42330 1/20 0.54
AKR1C2 P52895 1/20 0.54
AKR1C1 Q04828 1/20 0.54
RXFP1 Q9HBX9 1/20 0.53
DHODH Q02127 2/20 0.52
TACR3 P29371 2/20 0.52
PARP1 P09874 2/20 0.51
MAPT P10636 2/20 0.49
TP53 P04637 1/20 0.49
TRPV1 Q8NER1 1/20 0.49
ALDH1A1 P00352 1/20 0.49
KMO O15229 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2373465 0.90 KDM4E (0.69) CA12CA1CA2CA9KDM4E
SCHEMBL8617534 0.85 CA12 (0.64) CA12CA1CA2CA9KDM4E
SCHEMBL30690068 0.84 DHODH (0.63) CA12CA1CA2CA9KDM4E
SCHEMBL29586433 0.84 LMNA (0.76) KDM4ELMNASMN1; SMN2PDE10AAKR1C3
SCHEMBL379807 0.84 LMNA (0.76) KDM4ELMNASMN1; SMN2PDE10AAKR1C3
SCHEMBL10760636 0.82 CA12 (0.55) CA12CA1CA2CA9KDM4E
SCHEMBL10610235 0.80 CA12 (0.54) CA12CA1CA2CA9KDM4E
SCHEMBL2373131 0.80 ALDH1A1 (0.61) CA12CA1CA2CA9KDM4E
SCHEMBL17268111 0.79 TACR3 (0.82) CA12CA1CA2CA9KDM4E
SCHEMBL2384992 0.78 TACR3 (0.70) CA12CA1CA2CA9TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2549872-A1 TRPV4 ANTAGONISTS GlaxoSmithKline LLC (US) 2013-01-30 EP claimed
WO-2011119704-A1 TRPV4 ANTAGONISTS GLAXOSMITHKLINE LLC (US) 2011-09-29 WO claimed
WO-2011119701-A1 TRPV4 ANTAGONISTS GLAXOSMITHKLINE LLC (US) 2011-09-29 WO claimed
EP-2549872-A1 TRPV4 ANTAGONISTS GlaxoSmithKline LLC (US) 2013-01-30 EP disclosed
WO-2011119704-A1 TRPV4 ANTAGONISTS GLAXOSMITHKLINE LLC (US) 2011-09-29 WO disclosed
WO-2011119701-A1 TRPV4 ANTAGONISTS GLAXOSMITHKLINE LLC (US) 2011-09-29 WO disclosed